Stemrim Co., Ltd.
Basic information
- Head office
- 3rd Floor, Saito Bio Incubator, 7-15 Saito Asagi 7-chome, Ibaraki City, Osaka Prefecture
- Chief executive
- Masato Okajima
- Capital
- 10,000,000
- Employees (non-consolidated)
- 69 people
- Employees (consolidated)
- 69 people
- Start date
- 2006-10-01
- End date
Websites
Business
Development of regenerative induction drugs® applicable to various diseases such as epidermolysis bullosa, cerebral infarction, myocardial infarction/myocarditisDevelopment of regenerative induction drugs®Collaborative research utilizing the company’s intellectual propertyLicensing
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
|
|
||||||||
|
|
||||||||
|
|
||||||||
|
|
Network
History
Founded in 2006 with the goal of developing the bone marrow-derived multipotent stem cell mobilizing factor identified by Professor Katsuhito Tamai of Osaka University Graduate School of Medicine into a pharmaceutical product, the company has consistently developed the functional tissue regeneration promoting drug "Regenerative Induction Drugs®" to enable treatment of refractory diseases.
Company establishment. Founded in 2006.
Established Genomix Co., Ltd. to develop the bone marrow-derived multipotent stem cell mobilizing factor identified by Professor Katsuhito Tamai of Osaka University Graduate School of Medicine into a pharmaceutical product.
Initiated joint research with Osaka University.
Selected for the JST Industry-Academia Seed Innovation Project.
Selected for the JST A-STEP Full-scale Research and Development High-risk Challenge type.
Moved headquarters to Saito Bio Incubator (Ibaraki City, Osaka Prefecture). Opened Saito Lab. Signed a joint research agreement with Shionogi & Co., Ltd. on bone marrow-derived stem cell mobilizing factor.
Moved headquarters to Saito Bio Incubator (Ibaraki City, Osaka Prefecture). Opened Saito Lab.
Signed a joint research agreement with Shionogi & Co., Ltd. on bone marrow-derived stem cell mobilizing factor.
Selected for the JST A-STEP Full-scale Research and Development Seed Cultivation type. Selected for the AMED 2024 Reproductive, Cellular, and Gene Therapy Industrialization Promotion Project.
Selected for the JST A-STEP Full-scale Research and Development Seed Cultivation type.
Selected for the AMED 2024 Reproductive, Cellular, and Gene Therapy Industrialization Promotion Project.
News
There is no news.
Public records
National Tax Agency basic information6120901018131
- Trade name
- 株式会社ステムリム
- Trade name (kana)
- ステムリム
- Name in English
- Corporation type
- 301
- Address
- 〒567-0085 大阪府茨木市彩都あさぎ７丁目７番１５号
- Postal code
- 5670085
- Prefecture code
- 27
- City code
- 211
- Address outside Japan
- Prefecture in English
- City in English
- Address outside Japan in English
- Corporate number assignment date
- 2015-10-05
- Update date
- 2018-07-13
- Change date
- 2018-07-05
- Registry closure date
- Reason for registry closure
- Successor corporate number
- Details of the change
- Latest record
- 1
- Excluded from search
- 0
- Processing type
- 11
- Correction type
- 0
- Trade name image ID
- Address image ID
- Sequence number
- 4290672
METI gBizINFO6120901018131
- Corporate number
- 6120901018131
- Trade name
- 株式会社ステムリム
- Trade name (kana)
- ステムリム
- Trade name (alphabet)
- Registry closure date
- Reason for registry closure
- Registered address
- 大阪府茨木市彩都あさぎ７丁目７番１５号
- Postal code
- 5670085
- Prefecture
- 大阪府
- Prefecture code
- 27
- City or district
- 茨木市
- City code
- 211
- Street address
- 彩都あさぎ７丁目７番１５号
- Organisation type
- 301
- Processing type
- 11
- Correction type
- 0
- Status
- Representative
- 代表取締役社長CEO 岡島 正恒
- Capital
- 10000000
- Employees
- 45
- Employees (male)
- 19
- Employees (female)
- 26
- Business summary
- 再生誘導医薬の研究開発
- Website URL
- https://stemrim.com/
- Year founded
- Business category
- L:学術研究、専門・技術サービス業
- Date established
- Unified government qualification - grade
- Unified government qualification - business items
- Update date
- 2018-07-13
- Key information
- 6120901018131